Aptevo Therapeutics (APVO) Net Equity Issued and Repurchased (2015 - 2026)
Aptevo Therapeutics (APVO) recorded Net Equity Issued and Repurchased of $726,000 in Q2 2026, down 94.9% from $14.36 million a year earlier and down 16.7% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
On a TTM basis, Aptevo Therapeutics' Net Equity Issued and Repurchased came in at $25.17 million as of Jun 30, 2026, up 23.2% year-over-year; for FY2025, it came in at $37.94 million, up 278.0% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $10.04 million in FY2024 (+56.1%), $6.43 million in FY2023 (-7.3%), $6.93 million in FY2022 (-32.2%) and $10.23 million in FY2021 (-51.8%).
- Quarterly Net Equity Issued and Repurchased has ranged from -$8.56 million in Q3 2025 to $32.14 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $872,000 (Q1 2026), $32.14 million (Q4 2025) and -$8.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Aptevo Therapeutics | 2.58 Mn | -64.42 Mn | - | 726,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 726,000.00 |
| Mar 31, 2026 | 872,000.00 |
| Dec 31, 2025 | 32.14 Mn |
| Sep 30, 2025 | -8.56 Mn |
| Jun 30, 2025 | 14.36 Mn |
| Dec 31, 2024 | 266,000.00 |
| Sep 30, 2024 | 5.80 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 481,000.00 |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 506,000.00 |
| Dec 31, 2018 | 51,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Jun 30, 2018 | 378,000.00 |
| Mar 31, 2018 | 186,000.00 |
| Dec 31, 2017 | 442,000.00 |
| Dec 31, 2016 | 26.22 Mn |
API Access
Aptevo Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();